Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CPH/BAVA stock hub

CPH/BAVA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/BAVAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.6B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/BAVA

In the news

Latest news · CPH/BAVA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.1

P25 14.6P50 19.5P75 24.2

Trailing P/E10.8

P25 11.8P50 20.8P75 32.9

ROE11.3

P25 -4.6P50 11.3P75 24.2

ROIC7.9

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/BAVA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

DKK

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	1,692
Employees Change	87%
Employees Change Percent	5.42
Enterprise value	DKK 11.3B
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Biotechnology
Isin	DK0015998017
Last refreshed	2026-05-10
Market cap	DKK 14.6B
Price	DKK 190
Price currency	DKK
Rev Per Employee	3,690,281.32x
Sector	Healthcare
Sic	2836
Symbol	cph/BAVA
Website	https://www.bavarian-nordic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.45%
EV Earnings	8.24x
EV/EBIT	10.96x
EV/EBITDA	6.74x
EV/FCF	4.51x
EV/Sales	1.82x
FCF yield	17.29%
Forward P/E	22.09x
P/B ratio	1.13x
P/E ratio	10.78x
P/S ratio	2.33x
PE Ratio3 Y	15.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.58%
EBITDA Margin	26.48%
FCF margin	40.3%
Gross margin	49.2%
Gross Profit	DKK 3.1B
Gross Profit Growth	8.98%
Gross Profit Growth Q	-53.39%
Gross Profit Growth3 Y	21.77%
Gross Profit Growth5 Y	35.47%
Net Income	DKK 1.4B
Net Income Growth	39.21%
Net Income Growth Years	1%
Net Income Growth5 Y	37.73%
Pretax Margin	28.84%
Profit Margin	22.03%
Profit Per Employee	DKK 812,871
Profitable Years	3
ROA	4.41
Roa5y	3.34
ROCE	7.75
ROE	11.33
Roe5y	4.99
ROIC	7.92
Roic5y	8.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.15%
Cagr15y	8.06%
Cagr1y	22.8%
Cagr20y	-1.35%
Cagr3y	1.37%
Cagr5y	-6.78%
EPS Growth	39.68
EPS Growth Years	1
EPS Growth5 Y	28.11
FCF Growth	34.78%
FCF Growth Q	-51.76%
FCF Growth5 Y	48.45%
OCF Growth	39.6%
OCF Growth Q	-42.95%
OCF Growth10 Y	38.43%
OCF Growth3 Y	131.27%
OCF Growth5 Y	36.62%
Revenue Growth	9.23x
Revenue Growth Q	-30.71x
Revenue Growth Years	1x
Revenue Growth3 Y	25.61x
Revenue Growth5 Y	27.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.43
Assets	DKK 15B
Cash	DKK 3.3B
Current Assets	DKK 6.7B
Current Liabilities	DKK 1.6B
Debt	DKK 130.9M
Debt EBITDA	DKK 0.08
Debt Equity	DKK 0.01
Debt FCF	DKK 0.05
Equity	DKK 12.9B
Interest Coverage	167.4
Liabilities	DKK 2.1B
Long Term Assets	DKK 8.2B
Long Term Liabilities	DKK 486.9M
Net Cash	DKK 3.2B
Net Cash By Market Cap	DKK 22.08
Net Cash Growth	56.92%
Net Debt EBITDA	DKK -1.94
Net Debt Equity	DKK -0.25
Net Debt FCF	DKK -1.28
Tangible Book Value	DKK 6.9B
Tangible Book Value Per Share	DKK 88.29
WACC	9.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.22
Inventory Turnover	1.31
Net Working Capital	DKK 1.8B
Quick ratio	2.62
Working Capital	DKK 5.1B
Working Capital Turnover	DKK 1.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-1.52%
1Y total return	22.78%
200-day SMA	207.7
3Y total return	4.17%
50-day SMA	190.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-29.61%
All Time High	646
All Time High Change	-70.63%
All Time High Date	2007-06-06
All Time Low	35
All Time Low Change	442%
All Time Low Date	2002-09-30
ATR	4.1
Beta	0.95
Beta1y	0.65
Beta2y	1.2
Ch YTD	-0.6
High	189.7
High52	244.8
High52 Date	2025-08-22
High52ch	-22.51%
Low	185.7
Low52	153.5
Low52 Date	2025-05-08
Low52ch	25.75%
Ma50ch	-0.27%
Price vs 200-day SMA	-8.67%
RSI	48.54
RSI Monthly	48.61
RSI Weekly	45.88
Sharpe ratio	0.56x
Sortino ratio	0.98
Total Return	0.1%
Tr YTD	-0.6
Tr15y	219.74%
Tr1m	-2.37%
Tr1w	0.9%
Tr3m	-1.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 1B
Operating Income Growth	-2.2
Operating Income Growth Q	-93.89
Operating Income Growth5 Y	21.21
Operating margin	16.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	76,577,988%
Net Borrowing	-42,903,000
Shares Insiders	0.18%
Shares Institutions	32.73%
Shares Out	76,712,971
Shares Qo Q	-9.99%
Shares Yo Y	-0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 2.4B
Average Volume	176,067.55x
Bv Per Share	164.4
CAPEX	DKK -205.3M
Ch10y	-22.09
Ch15y	152.9
Ch1m	-2.37
Ch1w	0.9
Ch1y	22.78
Ch20y	-62.73
Ch3m	-1.91
Ch3y	4.17
Ch5y	-29.61
Ch6m	0.18
Change	0.16%
Change From Open	1.01
Close	189.4
Days Gap	-0.84
Depreciation Amortization	618,639,000
Dollar Volume	25,766,761.3
Earnings Date	2026-05-13
EBIT	DKK 1B
EBITDA	DKK 1.7B
EPS	DKK 17.6
F Score	7
FCF	DKK 2.5B
FCF EV Yield	22.19x
FCF Per Share	DKK 32.81
Financing CF	-114,358,000
Fiscal Year End	December
Founded	1,992
Graham Number	260.15015
Graham Upside	37.14
Income Tax	DKK 425.6M
Investing CF	-2,484,867,000
Is Primary Listing	1
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Lynch Fair Value	DKK 448
Lynch Upside	136.3
Ma150	198.8
Ma150ch	-4.57%
Ma20	191.6
Ma20ch	-0.98%
Net CF	91,008,000
Next Earnings Date	2026-05-13
Open	187.8
P FCF Ratio	5.78
P OCF Ratio	5.35
Position In Range	100
Ppne	2,169,161,000
Price Date	2026-05-08
Price EBITDA	DKK 8.8
Ptbv Ratio	2.11
Relative Volume	0.77x
Revenue	6,243,956,000x
SBC By Revenue	1.35x
Share Based Comp	84,486,000
Tax By Revenue	6.82x
Tax Rate	23.63%
Tr20y	-23.82%
Tr6m	0.18%
Volume	135,829
Z Score	6.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CPH/BAVA pay a dividend?

Capital-return profile for this ticker.

Performance

CPH/BAVA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/BAVA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.7%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

CPH/BAVA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.5

Neutral momentum band

Price vs 200-day MA

-8.7%

50/200-day relationship not available

Beta (5Y)

0.95

Moves roughly with the market

Sharpe ratio

0.56

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/BAVA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/BAVA stock rating?

cph/BAVA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/BAVA analysis?

The full report lives at /stocks/cph/BAVA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/BAVA?

The latest report frames cph/BAVA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/BAVA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.